| Financial Year |
September 30 2022 |
| Monetary Funds |
130,459,028.28 |
| Held-for-trading Financial Assets |
170,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
63,821,847.19 |
| Advances to Suppliers |
28,447,784.33 |
| Other Receivables |
106,925,471.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
126,099,151.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,995,065.36 |
| Total Current Assets |
639,748,347.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
50,539,142.78 |
| Fixed Assetes |
2,401,165.71 |
| Under-construction Projects |
7,861,273.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,406,969.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,620,579.63 |
| Deferred Income Tax Assets |
27,683,402.98 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
414,562,452.05 |
| Total Assets |
1,054,310,799.70 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
32,213,186.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,433,759.36 |
| Taxes Payable |
3,571,759.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,268,613.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,294,964.63 |
| Other Current Liabilities |
1,449,850.92 |
| Sub-Total of Current Liabilities |
191,911,342.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,293,394.86 |
| Deferred Income Tax Liabilities |
2,699,494.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,349,102.83 |
| Total Liabilities |
251,260,445.23 |
| Paid-In Capital(Or Share Stock) |
712,519,844.00 |
| Capital Surplus |
1,310,729,745.70 |
| Surplus Reserve |
65,552,111.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,308,280,352.39 |
| Minority Stockholder's Interest |
962,566.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
802,087,788.09 |
| Owner's Equity（Stockholder's Equity） |
803,050,354.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,054,310,799.70 |
